Chemoinformaics analysis of methyl 4-o-acetyl-2,3-di-o-methyl-alpha-d-xylopyranoside
| Molecular Weight | 234.248 | nRot | 4 |
| Heavy Atom Molecular Weight | 216.104 | nRig | 7 |
| Exact Molecular Weight | 234.11 | nRing | 1 |
| Solubility: LogS | -0.125 | nHRing | 1 |
| Solubility: LogP | 0.334 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 33.5143 |
| nHD | 0 | BPOL | 27.6057 |
| QED | 0.635 |
| Synth | 3.718 |
| Natural Product Likeliness | 1.88 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.14 |
| Pgp-sub | 0.025 |
| HIA | 0.022 |
| CACO-2 | -4.662 |
| MDCK | 0.0000598 |
| BBB | 0.328 |
| PPB | 0.15318 |
| VDSS | 0.833 |
| FU | 0.786239 |
| CYP1A2-inh | 0.017 |
| CYP1A2-sub | 0.362 |
| CYP2c19-inh | 0.008 |
| CYP2c19-sub | 0.571 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.009 |
| CYP2d6-inh | 0.044 |
| CYP2d6-sub | 0.142 |
| CYP3a4-inh | 0.014 |
| CYP3a4-sub | 0.334 |
| CL | 3.146 |
| T12 | 0.633 |
| hERG | 0.148 |
| Ames | 0.469 |
| ROA | 0.054 |
| SkinSen | 0.493 |
| Carcinogencity | 0.209 |
| EI | 0.985 |
| Respiratory | 0.028 |
| NR-Aromatase | 0.034 |
| Antiviral | No |
| Prediction | 0.838338 |